- ISIN
- CA22717L1013
- CUSIP
- 22717L101
- Sector
- Healthcare
- IPO Date
- Jul 12, 2016
Highlights
- Market Cap
- $1.06B
- Enterprise Value
- $237.09M
- EPS (TTM)
- -$0.01
- Total Revenue (TTM)
- $220.07M
- Gross Profit (TTM)
- $68.18M
- EBITDA (TTM)
- $2.28M
- Year Range
- $1.93 - $3.43
- Target Price
- $2.30
- ROA (TTM)
- -0.16%
- ROE (TTM)
- -0.17%
- Avg. Volume (1M)
- 807K
- Avg. Volume Value (1M)
- $2.26M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CRON Performance Chart
Cronos Group Inc. (CRON) is up 7.6% since the beginning of the year. At $3 per share, CRON is trading 17.5% below its 52-week high of $3. Investors who bought $1,000 worth of CRON shares 5 years ago would now be looking at an investment worth $384.
Loading charts...
Compare this symbol against anything
Returns By Period
Cronos Group Inc. (CRON) has returned 7.60% so far this year and 45.13% over the past 12 months. Looking at the last ten years, CRON has achieved an annualized return of 22.63%, outperforming the S&P 500 Index benchmark, which averaged 13.26% per year.
Cronos Group Inc.
- 1D
- -2.08%
- 1M
- -1.05%
- 6M
- 12.75%
- YTD
- 7.60%
- 1Y
- 45.13%
- 3Y*
- 14.00%
- 5Y*
- -17.42%
- 10Y*
- 22.63%
- ALL TIME*
- 32.60%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
CRON Monthly Returns History
Based on dividend-adjusted daily data since Jul 12, 2016, CRON's average daily return is +0.22%, while the average monthly return is +4.62%. At this rate, an investment would double in approximately 1.3 years.
Historically, 45% of months were positive and 55% were negative. The best month was Dec 2017 with a return of +133.8%, while the worst month was Oct 2018 at -33.3%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.
On a daily basis, CRON closed higher 45% of trading days. The best single day was Jul 15, 2016 with a return of +45.5%, while the worst single day was Aug 30, 2018 at -28.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.56% | 6.37% | -5.99% | 6.37% | 6.37% | -2.11% | 1.80% | 7.60% | |||||
| 2025 | -5.94% | 7.89% | -11.71% | 3.87% | 5.32% | -3.54% | 3.66% | 31.31% | 6.92% | -9.71% | -1.59% | 6.48% | 30.20% |
| 2024 | -4.31% | 4.00% | 25.48% | 12.64% | -11.90% | -10.04% | 5.15% | -7.76% | -3.10% | -4.57% | -0.48% | -2.88% | -3.35% |
| 2023 | -0.79% | -13.89% | -10.60% | -3.61% | -6.42% | 12.57% | -1.52% | 5.67% | -2.44% | -9.50% | 11.60% | 3.47% | -17.72% |
| 2022 | -5.87% | -2.98% | 8.66% | -22.37% | -0.33% | -6.31% | 11.70% | -3.17% | -7.54% | 17.38% | -6.04% | -18.33% | -35.20% |
| 2021 | 49.14% | 0.97% | -9.47% | -13.95% | 10.69% | -4.55% | -14.30% | -10.31% | -14.37% | -8.30% | -12.72% | -13.47% | -43.52% |
Benchmark Metrics
Cronos Group Inc. has an annualized alpha of 47.61%, beta of 1.13, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since July 12, 2016.
- This stock captured 144.43% of S&P 500 Index gains but only 63.37% of its losses - a favorable profile for investors.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 47.61%
- Beta
- 1.13
- R²
- 0.08
- Upside Capture
- 144.43%
- Downside Capture
- 63.37%
Return for Risk
Risk / Return Rank
CRON ranks 73 for risk / return — above 73% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Cronos Group Inc. (CRON) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRON | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.48 | ||
| Sortino ratioReturn per unit of downside risk | -0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.25 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 1.60 | 2.00 | -0.40 |
| Martin ratioReturn relative to average drawdown | 2.65 | 8.49 | -5.84 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cronos Group Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cronos Group Inc. was 93.16%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Cronos Group Inc. drawdown is 88.06%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-93.16%Apr 2025 | 6y 1mo | — | 7y 5moMar 2019 - now | 2025 selloff2025 |
-51.36%Jun 2017 | 2mo 11d | 3mo 24d | 6mo 5dApr 2017 - Oct 2017 | — |
-50.55%Oct 2018 | 1mo 8d | 2mo 17d | 3mo 25dSep 2018 - Jan 2019 | Rate-hike selloffLate 2018 |
-49.73%Feb 2018 | 23d | 6mo 26d | 7mo 19dJan 2018 - Aug 2018 | — |
-29.63%Dec 2016 | 1mo 6d | 13d | 1mo 19dNov 2016 - Jan 2017 | — |
Drawdown Indicators
| CRON | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.16% | -56.78% | -36.38% |
Max Drawdown (1Y)Largest decline over 1 year | -26.91% | -9.10% | -17.81% |
Max Drawdown (3Y)Largest decline over 3 years | -46.36% | -18.90% | -27.46% |
Max Drawdown (5Y)Largest decline over 5 years | -78.14% | -25.43% | -52.71% |
Max Drawdown (10Y)Largest decline over 10 years | -93.16% | -33.92% | -59.24% |
Current DrawdownCurrent decline from peak | -88.06% | -1.58% | -86.48% |
Average DrawdownAverage peak-to-trough decline | -63.93% | -10.70% | -53.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.26% | 2.14% | +14.12% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cronos Group Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Cronos Group Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CRON relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CRON has a P/S ratio of 3.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CRON
Add Cronos Group Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CRON